Free Trial
OTCMKTS:MYRX

Myrexis (MYRX) Stock Price, News & Analysis

$0.0008 0.00 (0.00%)
As of 10/15/2026

About Myrexis Stock (OTCMKTS:MYRX)

Advanced

Key Stats

Today's Range
$0.0008
▼
$0.0008
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0070
Volume
N/A
Average Volume
154 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Myrexis, Inc. was a biopharmaceutical company focused on the discovery and development of small-molecule medicines for cancer and other serious diseases. The company’s work centered on developing proprietary drug candidates intended to address unmet medical needs.

Myrexis operated as a development-stage biotechnology company rather than a commercial pharmaceutical manufacturer. Its historical pipeline included Azixa, also known as MX-6220, an investigational oncology compound studied for potential use in treating cancer.

The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in 2012. Publicly available information indicates that the company subsequently discontinued its operations and no longer maintains a significant active commercial product portfolio. Detailed current information about its leadership, geographic operations and business activities is limited.

AI Generated. May Contain Errors.

Receive MYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Myrexis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MYRX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

MYRX Stock Analysis - Frequently Asked Questions

Myrexis' stock was trading at $0.0004 at the start of the year. Since then, MYRX stock has increased by 100.0% and is now trading at $0.0008.

Shares of MYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/16/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:MYRX
CIK
1459450
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
2.96
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:MYRX) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners